Windtree Therapeutics (WINT) Earnings Date & Reports

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

WINT is expected to report earnings to fall 19.11% to -1050 cents per share on May 17

Windtree Therapeutics WINT Stock Earnings Reports

Q1'23

Est.

$-10.50

Q4'22

Missed

by $2.48

Q3'22

Beat

by $0.13

Q2'22

Missed

by $0.41

Q1'22

Beat

by $0.01

The last earnings report on March 30 showed earnings per share of -1297 cents, missing the estimate of -1050 cents. With 80.05K shares outstanding, the current market capitalization sits at 1.04M.

View a ticker or compare two or three

Compare

WINT